Références
Bottomley A (1998) Depression in cancer patients: a literature review. Eur J Cancer Care (Engl) 7(3): 181–191
Diquet B, Laine-Cessac P (2005) The search for risk factors and the therapeutic consequences. Drug interactions. Rev Prat 55: 541–545
Lloyd-Williams M (2001) Screening for depression in palliative care patients: a review. Eur J Cancer 10(1): 31–35
Lloyd-Williams M, Friedman T, Rudd N (1999) A survey of antidepressant prescribing in the terminally ill. Palliat Med 13(3): 243–248
Reich M (2010) Les antidépresseurs en oncologie: spécificités et particularités. Psycho-Oncologie 4: 51–64
Saravane D, Gilquin AFL (2011) Cancers et psychoses. Santé Mentale 163: 44–47
Scheen AJ (2006) Interactions médicamenteuses: de la théorie à la pratique. Rev Med Liege 61: 5–6, 471–82
Sela RA (2007) Screening for depression in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care 5(3): 207–217
Stiefel FC, Kornblith AB, Holland JC (1990) Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer 65(4): 1048–1053
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Grudé, F., Bessard, R., Bourgeois, H. et al. Les traitements antitumoraux chez les patients traités pour une pathologie psychiatrique. Oncologie 15, 35–36 (2013). https://doi.org/10.1007/s10269-012-2244-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-012-2244-3